Targeted Screening Strategies to Detect Trypanosoma cruzi Infection in Children
Authors:
Open Access
- 26 December 2007
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 1 (3) , e103
Abstract
Millions of people are infected with Trypanosoma cruzi, the causative agent of Chagas disease in Latin America. Anti-trypanosomal drug therapy can cure infected individuals, but treatment efficacy is highest early in infection. Vector control campaigns disrupt transmission of T. cruzi, but without timely diagnosis, children infected prior to vector control often miss the window of opportunity for effective chemotherapy. We performed a serological survey in children 2–18 years old living in a peri-urban community of Arequipa, Peru, and linked the results to entomologic, spatial and census data gathered during a vector control campaign. 23 of 433 (5.3% [95% CI 3.4–7.9]) children were confirmed seropositive for T. cruzi infection by two methods. Spatial analysis revealed that households with infected children were very tightly clustered within looser clusters of households with parasite-infected vectors. Bayesian hierarchical mixed models, which controlled for clustering of infection, showed that a child's risk of being seropositive increased by 20% per year of age and 4% per vector captured within the child's house. Receiver operator characteristic (ROC) plots of best-fit models suggest that more than 83% of infected children could be identified while testing only 22% of eligible children. We found evidence of spatially-focal vector-borne T. cruzi transmission in peri-urban Arequipa. Ongoing vector control campaigns, in addition to preventing further parasite transmission, facilitate the collection of data essential to identifying children at high risk of T. cruzi infection. Targeted screening strategies could make integration of diagnosis and treatment of children into Chagas disease control programs feasible in lower-resource settings. Chagas disease kills more people than any other parasitic disease in the Americas. The disease is caused by Trypanosoma cruzi, a single-cell parasite which is transmitted between people and other mammals by triatomine insects. Chagas disease control programs in Latin America have focused mainly on stopping transmission of T. cruzi rather than active surveillance for infection among human populations at risk. These programs have been very successful in controlling triatomine insects by spraying households with insecticides. This article is the first to describe T. cruzi transmission in an urban environment and show evidence that transmission may be epidemic in the city of Arequipa, Peru. The article also demonstrates how data easily collected during an ongoing insecticide spraying campaign in Arequipa might be used to identify children at greatest risk of infection with T. cruzi. The results of the analysis might aid in the optimal use of limited diagnostic resources by targeting screening efforts to those children in greatest need of diagnosis. Such targeted screening could facilitate the integration of diagnosis and treatment of children into Chagas disease control programs currently focused primarily on insects.Keywords
This publication has 28 references indexed in Scilit:
- Periurban Trypanosoma cruzi–infected Triatoma infestans, Arequipa, PeruEmerging Infectious Diseases, 2006
- Trypanocidal drugs for late stage, symptomatic Chagas disease (Trypanosoma cruzi infection)Cochrane Database of Systematic Reviews, 2005
- INCIDENCE OF TRYPANOSOMA CRUZI INFECTION AMONG CHILDREN FOLLOWING DOMESTIC REINFESTATION AFTER INSECTICIDE SPRAYING IN RURAL NORTHWESTERN ARGENTINAThe American Journal of Tropical Medicine and Hygiene, 2005
- Residual Spatial Correlation Between Geographically Referenced ObservationsEpidemiology, 2005
- Prevalencia de la enfermedad de Chagas en puérperas y transmisión congénita en una zona endémica del PerúRevista Panamericana de Salud Pública, 2005
- Congenital Transmission of Trypanosoma cruzi Infection in ArgentinaEmerging Infectious Diseases, 2003
- Ageing with Trypanosoma cruzi infection in a community where the transmission has been interrupted: the Bambuí Health and Ageing Study (BHAS)International Journal of Epidemiology, 2001
- Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infectionThe Lancet, 1996
- AMERICAN TRYPANOSOMIASIS (CHAGAS' DISEASE)Gastroenterology Clinics of North America, 1996
- Malaria vaccines: lessons from field trialsCadernos de Saude Publica, 1994